Case Report: Therapeutic and immunomodulatory effects of plasmapheresis in long-haul COVID [version 2; peer review: 2 approved]

Case Report: Therapeutic and immunomodulatory effects of plasmapheresis in long-haul COVID [version 2; peer review: 2 approved]

Many patients with COVID-19 experience a range of debilitating symptoms months after being infected, a syndrome termed long-haul COVID. A 68-year-old male presented with lung opacity, fatigue, physical and cognitive weaknesses, loss of smell and lymphocytopenia. After rounds of therapeutic plasma ex...

Full description

Bibliographic Details
Main Authors: Michael J. Conboy, Irina M. Conboy, Etsuko Watanabe, Chao Liu, Regina Rohe, Jan C. Hoffman, Ahvie Herskowitz, Dobri D. Kiprov, Michael Lieb, Daehwan Kim
Format: Article
Language:English
Published: F1000 Research Ltd 2022-04-01
Series:F1000Research
Subjects:
Immunomodulation
Long Haul Covid19
plasmapheresis
adaptive immunity
inflammation
proteomics
eng
Online Access:https://f1000research.com/articles/10-1189/v2

Internet

https://f1000research.com/articles/10-1189/v2

Similar Items